Cargando…

Vaccine effectiveness estimates from an early-season influenza A(H3N2) epidemic, including unique genetic diversity with reassortment, Canada, 2022/23

The Canadian Sentinel Practitioner Surveillance Network estimated vaccine effectiveness (VE) during the unusually early 2022/23 influenza A(H3N2) epidemic. Like vaccine, circulating viruses were clade 3C.2a1b.2a.2, but with genetic diversity affecting haemagglutinin positions 135 and 156, and reasso...

Descripción completa

Detalles Bibliográficos
Autores principales:	Skowronski, Danuta M, Chuang, Erica SY, Sabaiduc, Suzana, Kaweski, Samantha E, Kim, Shinhye, Dickinson, James A, Olsha, Romy, Gubbay, Jonathan B, Zelyas, Nathan, Charest, Hugues, Bastien, Nathalie, Jassem, Agatha N, De Serres, Gaston
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Centre for Disease Prevention and Control (ECDC) 2023
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896608/ https://www.ncbi.nlm.nih.gov/pubmed/36729117 http://dx.doi.org/10.2807/1560-7917.ES.2023.28.5.2300043

Ejemplares similares

Influenza vaccine effectiveness against A(H3N2) during the delayed 2021/22 epidemic in Canada
por: Kim, Shinhye, et al.
Publicado: (2022)

Interim estimates of 2019/20 vaccine effectiveness during early-season co-circulation of influenza A and B viruses, Canada, February 2020
por: Skowronski, Danuta M, et al.
Publicado: (2020)

Interim estimates of 2018/19 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, January 2019
por: Skowronski, Danuta M, et al.
Publicado: (2019)

Interim estimates of 2016/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017
por: Skowronski, Danuta M, et al.
Publicado: (2017)

Paradoxical clade- and age-specific vaccine effectiveness during the 2018/19 influenza A(H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV)
por: Skowronski, Danuta M, et al.
Publicado: (2019)

Influenza Vaccine Does Not Increase the Risk of Coronavirus or Other Noninfluenza Respiratory Viruses: Retrospective Analysis From Canada, 2010–2011 to 2016–2017
por: Skowronski, Danuta M, et al.
Publicado: (2020)

Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018
por: Skowronski, Danuta M, et al.
Publicado: (2018)

Children under 10 years of age were more affected by the 2018/19 influenza A(H1N1)pdm09 epidemic in Canada: ‎possible cohort effect following the 2009 influenza pandemic
por: Skowronski, Danuta M, et al.
Publicado: (2019)

Influenza Vaccine Effectiveness by A(H3N2) Phylogenetic Subcluster and Prior Vaccination History: 2016–2017 and 2017–2018 Epidemics in Canada
por: Skowronski, Danuta M, et al.
Publicado: (2020)

Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015–2016 Season in Canada
por: Skowronski, Danuta M, et al.
Publicado: (2017)

Vaccine Effectiveness Against Lineage-matched and -mismatched Influenza B Viruses Across 8 Seasons in Canada, 2010–2011 to 2017–2018
por: Skowronski, Danuta M, et al.
Publicado: (2019)

Risk of hospital admission and death from first-ever SARS-CoV-2 infection by age group during the Delta and Omicron periods in British Columbia, Canada
por: Skowronski, Danuta M., et al.
Publicado: (2023)

Age-Related Differences in Influenza B Infection by Lineage in a Community-Based Sentinel System, 2010–2011 to 2015–2016, Canada
por: Skowronski, Danuta M, et al.
Publicado: (2017)

Should Sex Be Considered an Effect Modifier in the Evaluation of Influenza Vaccine Effectiveness?
por: Chambers, Catharine, et al.
Publicado: (2018)

Low 2012–13 Influenza Vaccine Effectiveness Associated with Mutation in the Egg-Adapted H3N2 Vaccine Strain Not Antigenic Drift in Circulating Viruses
por: Skowronski, Danuta M., et al.
Publicado: (2014)

Serial cross-sectional estimation of vaccine-and infection-induced SARS-CoV-2 seroprevalence in British Columbia, Canada
por: Skowronski, Danuta M., et al.
Publicado: (2022)

A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014–2015 Season
por: Skowronski, Danuta M., et al.
Publicado: (2016)

Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009
por: Skowronski, Danuta M, et al.
Publicado: (2011)

BNT162b2 Effectiveness Against Delta and Omicron Variants of Severe Acute Respiratory Syndrome Coronavirus 2 in Adolescents Aged 12–17 Years, by Dosing Interval and Duration
por: Ionescu, Iulia G, et al.
Publicado: (2023)

Influenza Classification Suite: An automated Galaxy workflow for rapid influenza sequence analysis
por: Eisler, Diane, et al.
Publicado: (2020)

Other Respiratory Viruses Are Important Contributors to Adult Respiratory Hospitalizations and Mortality Even During Peak Weeks of the Influenza Season
por: Gilca, Rodica, et al.
Publicado: (2014)

Increase in Hospital Admissions for Severe Influenza A/B among Travelers on Cruise Ships to Alaska, 2015
por: Payne, Michael, et al.
Publicado: (2018)

Mid-Season Estimates of Influenza Vaccine Effectiveness against Influenza A(H3N2) Hospitalization in the Elderly in Quebec, Canada, January 2015
por: Gilca, Rodica, et al.
Publicado: (2015)

Ecological Fallacy, Nonspecific Outcomes, and the Attribution of Disproportionate Vaccine Benefits
por: De Serres, Gaston, et al.
Publicado: (2018)

Role of Egg-adaptation Mutations in Low Influenza A(H3N2) Vaccine Effectiveness During the 2012–2013 Season
por: Skowronski, Danuta M, et al.
Publicado: (2018)

Evidence in a Cluster Randomized Controlled Trial of Increased 2009 Pandemic Risk Associated With 2008–2009 Seasonal Influenza Vaccine Receipt
por: Skowronski, Danuta M, et al.
Publicado: (2019)

A case of reassortant seasonal influenza A(H1N2) virus, Denmark, April 2019
por: Trebbien, Ramona, et al.
Publicado: (2019)

Case of seasonal reassortant A(H1N2) influenza virus infection, the Netherlands, March 2018
por: Meijer, Adam, et al.
Publicado: (2018)

Age-Associated Seroprevalence of Coronavirus Antibodies: Population-Based Serosurveys in 2013 and 2020, British Columbia, Canada
por: Tanunliong, Guadalein, et al.
Publicado: (2022)

Novel influenza A(H1N2) seasonal reassortant identified in a patient sample, Sweden, January 2019
por: Wiman, Åsa, et al.
Publicado: (2019)

Multidrug-resistant organisms in patients from Ukraine in the Netherlands, March to August 2022
por: Zwittink, Romy D, et al.
Publicado: (2022)

Pathogenicity and genetic characterisation of a novel reassortant, highly pathogenic avian influenza (HPAI) H5N6 virus isolated in Korea, 2017
por: Kim, Young-Il, et al.
Publicado: (2018)

Caution Required in the Use of Administrative Data and General Laboratory Submissions for Influenza Vaccine Effectiveness Estimation
por: Skowronski, Danuta M, et al.
Publicado: (2019)

Investigation into cases of hepatitis of unknown aetiology among young children, Scotland, 1 January 2022 to 12 April 2022
por: Marsh, Kimberly, et al.
Publicado: (2022)

Contagious Period for Pandemic (H1N1) 2009
por: De Serres, Gaston, et al.
Publicado: (2010)

Adverse events following immunisation with four-component meningococcal serogroup B vaccine (4CMenB): interaction with co-administration of routine infant vaccines and risk of recurrence in European randomised controlled trials
por: Zafack, Joseline Guetsop, et al.
Publicado: (2019)

Autochthonous dengue in mainland France, 2022: geographical extension and incidence increase
por: Cochet, Amandine, et al.
Publicado: (2022)

Respiratory syncytial virus contributes to more severe respiratory morbidity than influenza in children < 2 years during seasonal influenza peaks
por: Amini, Rachid, et al.
Publicado: (2019)

Community transmission of monkeypox in the United Kingdom, April to May 2022
por: Vivancos, Roberto, et al.
Publicado: (2022)

Monkeypox infection presenting as genital rash, Australia, May 2022
por: Hammerschlag, Yael, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q7hlqsqiui8qb1fa79vs6fmttu